-
Mashup Score: 15
AbstractBackground. Based on interim analyses and modelling data, lower doses of bamlanivimab and etesevimab together (700mg/1400mg) were investigated to determ
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 5SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity - 3 year(s) ago
Abstract. The SARS-CoV-2 mRNA vaccine-induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT)
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Allogeneic hematopoietic stem cell transplant recipients are more likely to develop severe COVID-19. A new report in CID describes these patients' immune response to SARS-CoV-2 mRNA vaccines: https://t.co/N3LPwRFzar #ClinInfectDis #IDSAJournals https://t.co/d3fSFb5tZB
-
-
Mashup Score: 8COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021 - 3 year(s) ago
Abstract. We characterized COVID-19 breakthrough cases admitted to a single center in Florida. With the emergence of delta variant, an increased number of hospi
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A new article in CID describes trends and clinical characteristics among patients with SARS-CoV-2 vaccine-breakthrough infections who were hospitalized at a single center in Florida: https://t.co/45436fRglk #ClinInfectDis #IDSAJournals @pmorenofranco https://t.co/dtlHyZLKkA
-
-
Mashup Score: 1Resistance in Enterobacterales is higher among people with HIV - 3 year(s) ago
AbstractBackground. Multidrug-resistant Enterobacterales (MDR-E) are important pathogens. People with human immunodeficiency virus (HIV) may be at greater risk
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
CID: In a large health system in North Carolina, people with HIV had a consistently higher prevalence of antimicrobial-resistant Enterobacterales isolates than did people without HIV from 2000-2018. 📄: https://t.co/O1tKsZ4JKQ #IDSAJournals #ClinInfectDis https://t.co/XX2IJpCegn
-
-
Mashup Score: 3
AbstractObjective. We assessed vaccine effectiveness (VE) of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 acquisition among health care workers (HCWs) of l
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in CID: Among health care workers in long-term care facilities in Israel, two doses of the BNT162b2 vaccine were 89% effective against SARS-CoV-2 infection, with lower viral loads among vaccinated workers. 📄: https://t.co/nxY6iHgvWr #IDSAJournals #ClinInfectDis https://t.co/hQBEKB8yIp
-
-
Mashup Score: 11New Review Article Outlines Potential of SARS-CoV-2 Genetic Sequencing in Patient Care - 3 year(s) ago
Arlington, Va.– Nov. 3, 2021 – The rise of more transmissible variants of SARS-CoV-2 has spurred growing interest in harnessing information about the genetic sequences of these variants to help treat patients. A new joint consensus review from the Infectious Diseases Society of America and the American Society for Microbiology outlines the potential role of…
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
A new journal review from IDSA and @ASMicrobiology outlines the potential role of SARS-CoV-2 sequencing in clinical care and the challenges in implementing this process in laboratories. https://t.co/kVJBKDmZ3O The review: https://t.co/yunhpdGweU #IDSAJournals #ClinInfectDis https://t.co/w43lkhzeUg
-
-
Mashup Score: 4
AbstractBackground. Takeda’s live attenuated tetravalent dengue vaccine candidate (TAK-003) is under evaluation in a long-term clinical trial across eight dengu
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: https://t.co/KPGa1GNIVm #IDSAJournals #ClinInfectDis https://t.co/jkc2eSOOwj
-
-
Mashup Score: 18Association between Airborne Infection Isolation Room Utilization Rates and Healthcare Worker COVID-19 Infections in Two Academic Hospitals - 3 year(s) ago
Abstract. We compared healthcare worker SARS-CoV-2 infection rates between March-August 2020 in two similar hospitals with high versus low airborne infection is
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A study in CID found no difference in SARS-CoV-2 infection rates among health care workers in two hospitals with high vs low use of airborne infection isolation rooms but otherwise identical infection control policies: https://t.co/iSRl4vo7Yk #IDSAJournals #ClinInfectDis https://t.co/wEe3cAEI2q
-
-
Mashup Score: 18
AbstractObjective. Prompt initiation of antibiotic therapy improves the survival of patients with bloodstream infections (BSI). We sought to determine if the se
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
For patients with bloodstream infections, treatment with a β-lactam antibiotic before vancomycin may reduce early mortality, a new multicenter, observational study in CID suggests: https://t.co/DEesIwIof9 #IDSAJournals #ClinInfectDis https://t.co/tFycDS3nAE
-
-
Mashup Score: 2Call for Applications for Editor-in-Chief - 3 year(s) ago
Clinical Infectious Diseases (CID) An Official Journal of the Infectious Diseases Society of America
Source: Oxford AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Only two weeks left in the call for applications for the next editor-in-chief of CID! ID physician scientists w/ records of academic excellence in clinical research are encouraged to apply. Deadline Oct. 18: https://t.co/m1mTYhdK5X #IDSAJournals #ClinInfectDis https://t.co/F1uw44b2sy
-
A randomized trial in CID found that bamlanivimab & etesevimab together reduced hospitalizations & viral load in patients w/ mild-to-moderate COVID-19, supporting the combination’s use in ambulatory patients at high risk for severe disease: https://t.co/h5O4aJWGUW #ClinInfectDis https://t.co/gutHhck6IB